Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.
about
Intratumoural production of TNFα by bacteria mediates cancer therapy.Prostate stem cell antigen: a Jekyll and Hyde molecule?Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in miceEngineered T cells for pancreatic cancer treatmentOncolytic herpes simplex virus armed with xenogeneic homologue of prostatic acid phosphatase enhances antitumor efficacy in prostate cancer.An artificial PAP gene breaks self-tolerance and promotes tumor regression in the TRAMP model for prostate carcinomaAntitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma modelsLocal bacteria affect the efficacy of chemotherapeutic drugs.Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer.Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatmentsConstruction of a fusion plasmid containing the PSCA gene and cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) and its anti-tumor effect in an animal model of prostate cancer.DNA Vaccines for Prostate Cancer.DNA vaccination: using the patient's immune system to overcome cancerBacterial vectors for imaging and cancer gene therapy: a review.Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.The therapeutic efficacy of I131-PSCA-mAb in orthotopic mouse models of prostate cancer.Optimised electroporation mediated DNA vaccination for treatment of prostate cancer.Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line.Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.
P2860
Q33853333-FFF32976-17A6-433E-8026-133BCF529891Q34001130-04C07651-7C3D-4A4E-B5B2-415CD89F2A7EQ34472125-8F1F66C6-9514-4022-A4D4-E9B81ACE3F2EQ35244233-6483731C-3C72-44F4-ADD4-304F3992E669Q35625500-B6C8B50C-9E50-40B9-805E-86716FF5D3BDQ35802138-C8B7F50B-CB53-40BB-83CD-50D7BBDC37BEQ36076671-5EE9285C-38EF-4876-A319-1641B87D7DBFQ36102269-5589E9A3-B5B7-4C23-81A9-0EEC2248515DQ36936564-2F9D7D7E-5575-4443-A980-DC6BDB3E90A1Q37373927-E8032157-1EC1-4DA2-BE3F-328156D60122Q37384416-FCCEBA98-655A-47B7-BCD4-DE1A1A2CC5CDQ37604481-0B302ECB-D1DC-4685-9312-1695D2FCCBCDQ37825422-A3832CA4-631E-44D6-929F-78B6A643DE08Q38045229-FDA0230B-F2C1-43B6-83F3-BD97BA10250FQ38168921-2434B3FF-8F0A-4737-A6AB-8FC157E63CA3Q39044359-A5C81065-0C87-4BC6-AE49-6FB897067F22Q39312987-DAB04C08-EE51-46BB-B7CE-13EC2A69B093Q39595415-98AAC241-862C-470A-9560-ACC62BD066B7Q41435861-A8A6DCF6-FD06-468F-A604-D98BD55E2DE5Q41551352-8B691957-97EF-4654-B3F8-57180A647CF2Q41561252-E038F5AA-8D1A-4723-8E31-AA9D8F98C162Q45868822-B4A23A59-3D72-4F32-B71C-116F271F30B2
P2860
Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@en
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@nl
type
label
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@en
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@nl
prefLabel
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@en
Prostate stem cell antigen DNA ...... hibits prostate cancer growth.
@nl
P2093
P2860
P356
P1433
P1476
Prostate stem cell antigen DNA ...... nhibits prostate cancer growth
@en
P2093
Garrett Casey
Gerald C O'Sullivan
Paul Sweeney
Sarfraz Ahmad
P2860
P304
P356
10.1038/MT.2009.66
P50
P577
2009-03-31T00:00:00Z